Loading insider details...
Beta
Latest Form 4 (Jul 13, 2026): Grant/Award of 60,000 PLRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 13, 2026 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 60,000 | n/a |
| Jun 23, 2026 | Revolution Medicines, Inc. (RVMD) | Grant/Award | 1,191 | n/a |
| Jun 30, 2025 | Revolution Medicines, Inc. (RVMD) | Grant/Award | 3,142 | n/a |
| Jun 24, 2024 | Revolution Medicines, Inc. (RVMD) | Grant/Award | 4,800 | n/a |
| Jun 24, 2024 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 50,000 | n/a |
| Jun 12, 2023 | Revolution Medicines, Inc. (RVMD) | Grant/Award | 5,200 | n/a |
| Jun 9, 2023 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 40,000 | n/a |
| Jun 17, 2022 | Revolution Medicines, Inc. (RVMD) | Grant/Award | 5,200 | n/a |
| Jun 10, 2022 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 40,000 | n/a |
| Aug 17, 2021 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 80,000 | n/a |